Old organized bronchopulmonary dysplasia in the era of the new bronchopulmonary dysplasia

R Sancho-Hernández; M Rojas-Maruri; L Solorio-Rodríguez

2016, Number 3

<< Back Next >>

Acta Pediatr Mex 2016; 37 (3)

Old organized bronchopulmonary dysplasia in the era of the new bronchopulmonary dysplasia

Sancho-Hernández R, Rojas-Maruri M, Solorio-Rodríguez L

Full text

How to cite this article

Language: Spanish
References: 20
Page: 165-174
PDF size: 900.64 Kb.

Text Extraction

No abstract.

REFERENCES

Coalson J. Pathology of new bronchopulmonary displasia. Seminars in Neonatology. 2003;(8):73-81.
Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276(7):357-68.
Kair LR, et al. Bronchopulmonary dysplasia. Pediatrics in Review. 2012;33(6):255-263.
Jobe AH, Bancalari E. Bronchopulmonary Dysplasia. Am J Respir Crit Care Med. 2001;163(7):1723-29.
Mosca F, Colnaghi M, Fumagalli M. BDP: old and new problems. J Matern Fetal Neonatal Med. 2011;24(Supl 1):80-2.
Lahra MM, Beeby PJ, Jeffery HE. Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13 year hospital cohort study. Pediatrics. 2009;123 (5):1314-19.
Schelonka RL, Katz B, Waites KB, Benjamin DK Jr. Critical appraisal of the role of Ureaplasma in the development of bronchopulmonay dysplasia. Pediatr Pulmonol. 2001; doi 10.1002/ppul.21508
Watterberg KL, Scott SM, Backstrom C, et al. Links netween early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics. 2000;105 (2):320-24.
Bhandari A, Bhandari V. Piffalls, problems, and progress in bronchopulmonary displasia. Pediatrics. 2009;13(6):1562- 1573.
Atkinson SA. Special nutrition needs of infants for prevention of and recovery from bronchopulmonary displasia. J Nutr. 2001;131(3):942 S-946S.
Shah V, Ohlsson A, Halliday HL, Dunn MS. Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev. 2007;(4):CD001969.
Brion LP, Primhak RA. Intravenous or entereal loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2002;(1):CD001453.
Fok TF. Adjunctive pharmacotherapy in neonates with respiratory failure. Semin Fetal Neonatal Med. 2009;14(1):49- 55.
Denjean A, Paris-Llado J, Zupan V, et al. Inhaled salbutamol and beclomethasone for preventing bronchopulmnarydisplasia: a randomiseddouble blind study. Eur J Pediatr. 1998;157(11):926-31.
Cruz RJ, Pérez Fernández LF, Herrera GW, Granados NF. Neumopeitoneo causado por ventilación mecánica asistida. Acta PediatrMex. 2010;31(4):168-173.
Sancho HR, et al. Enfermedad secuelar enfisematosa intersticial en los niños: propuesta de una clasificación y experiencia en el tratamiento conservador y quirúrgico. Trabajo libre. 75 Congreso Neumología y Cirugía de Tórax. Guadalajara 2016.
Sancho HR, Pérez Fernández LF, Cuevas Schacht FJ. Enfisema lobar adquirido durante una neumopatía crónica intersticial: implicaciones quirúrgicas y revisión de la literatura. Acta Pediatr Mex. 2013;34:189-195.
Bourbon JR, Boucherat O, Boczkowski, et al. Bronchopulmonary dysplasia and emphysema: in search of common therapeutic targets. Trends in Molecular Medicine. 2009;15(4):169-179.
Yeh TF, Chen CM, Wu SY, et al. Intratracheal administration of budesonide/surfactant to prevent bronchopulmonary dysplasia. Amer J of Respiratory and Crit Car Med. 2016;193(1):86-95.
Bancalari E, Jain D. Prevention of bronchopulmonary dysplasia: are intratracheal steroids with surfactant a magic bullet? 2016;193(1):12.